Cure Putters continues to gain momentum each week with more and more Tour Professionals making Cure their flatstick of choice. This past weekend on the PGA Tour, a Cure CX1 was used to capture a T-4th Place Finish at the AT&T Byron Nelson. On the LPGA Tour, a Cure RX5 was used to capture Top-10 finishes in 4 of the last 5 events, including the most recent T-5th Place Finish at the Kingsmill Championship. On the PGA LATINOAMÉRICA Tour, a Cure RX3 was used for a T-9th Place Finish this week. Cure also had multiple putters in play at the Regions Tradition on the Champions Tour.
“The momentum we have on tour right now is incredible! We have full time reps on the PGA, LPGA and Champions Tour and we have a growing number of players using our putter and seeing great results and better putting stats. It’s great validation that our High MOI technology truly offers better performance to even players at the highest level. We’re creating a lot of buzz and the success we’ve seen on tour over the last few months has driven a tremendous amount of demand in the market both in the US and internationally. It’s a very exciting time for our small company,” said Jim McCarthy, Cure Putters CEO.